Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 31-40 of 167 (Search time: 0.012 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2012Research resource: interplay between the genomic and transcriptional networks of androgen receptor and estrogen receptor α in luminal breast cancer cellsNeed, E.; Selth, L.; Harris, T.; Birrell, S.; Tilley, W.; Buchanan, G.
2013False-positive TUNEL staining observed in SV40 based transgenic murine prostate cancer modelsLawrence, M.; Blyth, B.; Ormsby, R.; Tilley, W.; Sykes, P.
2012Evidence for efficacy of new Hsp90 inhibitors revealed by ex vivo culture of human prostate tumorsCentenera, M.; Gillis, J.; Hanson, A.; Jindal, S.; Taylor, R.; Risbridger, G.; Sutherland, P.; Scher, H.; Raj, G.; Knudsen, K.; Yeadon, T.; Tilley, W.; Butler, L.
2008The Contribution of Different Androgen Receptor Domains to Receptor Dimerization and SignalingCentenera, M.; Harris, J.; Tilley, W.; Butler, L.
2013Targeting cell cycle and hormone receptor pathways in cancerComstock, C.; Augello, M.; Goodwin, J.; de Leeuw, R.; Schiewer, M.; Ostrander, W.; Burkhart, R.; McClendon, A.; McCue, P.; Trabulsi, E.; Lallas, C.; Gomella, L.; Centenera, M.; Brody, J.; Butler, L.; Tilley, W.; Knudsen, K.
2014Androgen signalling and steroid receptor crosstalk in endocrine cancersClaessens, F.; Tilley, W.
2019Non-canonical AR activity facilitates endocrine resistance in breast cancerChia, K.; Milioli, H.; Portman, N.; Laven-Law, G.; Coulson, R.; Yong, A.; Segara, D.; Parker, A.; Caldon, C.; Deng, N.; Swarbrick, A.; Tilley, W.; Hickey, T.; Lim, E.
2013Identification of prostate cancer-associated microRNAs in circulation using a mouse model of diseaseSelth, L.; Townley, S.; Gillis, J.; Tilley, W.; Butler, L.
2013Constitutively-active androgen receptor variants function independently of the HSP90 chaperone but do not confer resistance to HSP90 inhibitorsGillis, J.; Selth, L.; Centenera, M.; Townley, S.; Sun, S.; Plymate, S.; Tilley, W.; Butler, L.
2015Co-targeting AR and HSP90 suppresses prostate cancer cell growth and prevents resistance mechanismsCentenera, M.; Carter, S.; Gillis, J.; Marrocco-Tallarigo, D.; Grose, R.; Tilley, W.; Butler, L.